Aridis Pharmaceuticals, Inc. Quarterly Depreciation in USD from Q3 2017 to Q3 2022

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: Aridis Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q3 2017 to Q3 2022.
Aridis Pharmaceuticals, Inc. Depreciation for the quarter ending September 30, 2022 was $123K, a 32.3% increase year-over-year.
Aridis Pharmaceuticals, Inc. Depreciation for the twelve months ending September 30, 2022 was $539K, a 51% increase year-over-year.
Aridis Pharmaceuticals, Inc. annual Depreciation for 2021 was $430K, a 29.5% increase from 2020.
Aridis Pharmaceuticals, Inc. annual Depreciation for 2020 was $332K, unchanged from 2019.
Aridis Pharmaceuticals, Inc. annual Depreciation for 2019 was $332K, a 19.4% increase from 2018.

Depreciation, Trailing 12 Months (USD)

Depreciation, Quarterly (USD)

Depreciation, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2022	$539K	$123K	+$30K	+32.3%	Jul 1, 2022	Sep 30, 2022	10-Q	2022-11-21
Q2 2022	$509K	$130K	+$39K	+42.9%	Apr 1, 2022	Jun 30, 2022	10-Q	2022-08-16
Q1 2022	$470K	$130K	+$40K	+44.4%	Jan 1, 2022	Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$430K	$156K	+$73K	+88%	Oct 1, 2021	Dec 31, 2021	10-K	2022-04-13
Q3 2021	$357K	$93K	+$10K	+12%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-21
Q2 2021	$347K	$91K	+$8K	+9.64%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-16
Q1 2021	$339K	$90K	+$7K	+8.43%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-16
Q4 2020	$332K	$83K	$0	0%	Oct 1, 2020	Dec 31, 2020	10-K	2022-04-13
Q3 2020	$332K	$83K	-$3K	-3.49%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	$335K	$83K	+$1K	+1.22%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020	$334K	$83K	+$2K	+2.47%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-11
Q4 2019	$332K	$83K	$0	0%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-30
Q3 2019	$332K	$86K	+$13K	+17.8%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-23
Q2 2019	$319K	$82K	+$10K	+13.9%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-11
Q1 2019	$309K	$81K	+$31K	+62%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-12
Q4 2018	$278K	$83K			Oct 1, 2018	Dec 31, 2018	10-K	2020-04-08
Q3 2018		$73K	+$61K	+508%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-13
Q2 2018		$72K			Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-12
Q1 2018		$50K			Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-14
Q3 2017		$12K			Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.